Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Laboratories, Bruker AXS, Gilson, SynBioSci, AnaSpec

Bio-Rad Laboratories this week launched ProteOn Manager 2.0, the latest ProteOn XPR36 protein interaction array system data management software. Key improvements to the product include enhancements that reduce processing and analysis time to 34 seconds from two minutes. It also features “one button” data processing, and the enhanced ability to easily move information and data in and out of ProteOn Manager 2.0.

Bruker AXS this week launched the Microstar Ultra II, the newest version of the company’s Microstar Ultra X-ray source for structural biology. According to the company, the instrument’s new Ultra Focus electron optics enhance intensity equivalent to “a doubling of the anode rotation frequency and thus produce an extremely high intensity X-ray beam, more than 30 times brighter than a conventional rotation anode generator.”
The company added the Microstar Ultra II “will change the way protein crystallography is done” by significantly reducing the effort and amount of time needed to determine routine de novo structures.

Gilson this week introduced Trilution LC v2.0 software. The updated product features improved fraction collection capabilities, speed, and performance, the company said in a statement. The software also incorporates Gilson’s 171 and 172 Photo Diode Array Detectors, also launched this week. Trilution LC v2.0 features special library creation, 3D and isoelectric plots as well as spectrum and peak purity.
Gilson’s new DADs feature remote flow technology that allows for “close proximity of the flow cell to the column output for fast response time to better ensure accurate collection of the analytes of interest,” the company said.

SynBioSci last week released its 2008 Peptide Catalog, listing more than 1,000 biologically active peptides in stock.

AnaSpec last week introduced 13 catalog peptides including Bak BH3 (71-89); Bim BH3 Fragment 1; TAMRA labeled; and Bcl9-2, mutant.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.